Therapeutic potential of pentamidine for glioma‐initiating cells and glioma cells through multimodal antitumor effects

por Tamai, Sho, Ichinose, Toshiya, Jiapaer, Shabierjiang, Hirai, Nozomi, Sabit, Hemragul, Tanaka, Shingo, Kinoshita, Masashi, Kobayashi, Masahiko, Hirao, Atsushi, Nakada, Mitsutoshi
Publicado 2023

The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma

por Saito, Norihiko, Hirai, Nozomi, Aoki, Kazuya, Suzuki, Ryo, Fujita, Satoshi, Nakayama, Haruo, Hayashi, Morito, Ito, Keisuke, Sakurai, Takatoshi, Iwabuchi, Satoshi
Publicado 2019

COT-12 Clinical feature of end-stage glioblastomas

por Saito, Norihiko, Hirai, Nozomi, Kushida, Naoki, Sato, Sho, Hiramoto, Yu, Fujita, Satoshi, Nakayama, Haruo, Hayashi, Morito, Ito, Keisuke, Iwabuchi, Satoshi
Publicado 2021

Genetic and Lineage Classification of Glioma-Initiating Cells Identifies a Clinically Relevant Glioblastoma Model

por Saito, Norihiko, Hirai, Nozomi, Aoki, Kazuya, Sato, Sho, Suzuki, Ryo, Hiramoto, Yu, Fujita, Satoshi, Nakayama, Haruo, Hayashi, Morito, Sakurai, Takatoshi, Iwabuchi, Satoshi
Publicado 2019

CBMS-03 PHOSPHORYLATION STATE OF OLIG2 REGULATES PROLIFERATION OF GLIOMA STEM CELLS

por Saito, Norihiko, Hirai, Nozomi, Aoki, Kazuya, Sato, Sho, Suzuki, Ryo, Hiramoto, Yu, Fujita, Satoshi, Nakayama, Haruo, Hayashi, Morito, Sakurai, Takatoshi, Iwabuchi, Satoshi
Publicado 2019

COT-20 Clinical experience with tumor-treating fields therapy for newly diagnosed glioblastoma

por Saito, Norihiko, Hirai, Nozomi, Sato, Sho, Hiramoto, Yu, Fujita, Satoshi, Nakayama, Haruo, Hayashi, Morito, Sakurai, Takatoshi, Yagihashi, Akinori, Takahagi, Shusaku, Iwabuchi, Satoshi
Publicado 2020

NQPC-15 DEVELOPMENT OF BRAIN TUMOR SURVIVORSHIP PROGRAM

por Saito, Norihiko, Hirai, Nozomi, Kushida, Naoki, Sato, Sho, Hiramoto, Yu, Fujita, Satoshi, Nakayama, Haruo, Hayashi, Morito, Ito, Keisuke, Sakurai, Takatoshi, Iwabuchi, Satoshi
Publicado 2022